ANAVEX LIFE SCIENCES CORP. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
ANAVEX LIFE SCIENCES CORP. (AVXL) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $314.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-08-28.
Financial Statements
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-28
- ANAVEX LIFE SCIENCES CORP. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $314.00K, a 78.33% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $1.11M, a 46.13% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $3.72M, a 84.85% increase year-over-year.
- ANAVEX LIFE SCIENCES CORP. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $4.32M, a 73.79% increase year-over-year.
- ANAVEX LIFE SCIENCES CORP. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $11.55M, a 22.37% increase from fiscal 2024.
- ANAVEX LIFE SCIENCES CORP. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $9.44M, a 42.35% decline from fiscal 2023.
- ANAVEX LIFE SCIENCES CORP. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $16.37M, a 10.93% decline from fiscal 2022.
- ANAVEX LIFE SCIENCES CORP. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $18.38M, a 123.29% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $314.00K 10-Q · filed 2026-08-28 | $1.42M 10-Q · filed 2026-08-28 | $5.14M derived: sum of 3 quarters · filed 2026-08-28 | $9.47M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-12-31 | $1.11M 10-Q · filed 2026-02-09 | $4.83M derived: sum of 2 quarters · filed 2026-08-28 | $9.15M derived: sum of 3 quarters · filed 2026-08-28 | $10.60M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-09-30 | $3.72M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | $8.04M derived: sum of 2 quarters · filed 2026-08-28 | $9.49M derived: sum of 3 quarters · filed 2026-08-28 | $11.55M 10-K/A · filed 2026-08-28 | ||||
| 2025-06-30 | $4.32M 10-Q · filed 2026-08-28 | $5.77M derived: sum of 2 quarters · filed 2026-08-28 | $7.83M 10-Q · filed 2026-08-28 | $9.84M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-03-31 | $1.45M 10-Q · filed 2026-08-28 | $3.50M 10-Q · filed 2026-08-28 | $5.52M derived: sum of 3 quarters · filed 2026-08-28 | $8.01M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2024-12-31 | $2.06M 10-Q · filed 2026-02-09 | $4.07M derived: sum of 2 quarters · filed 2026-08-28 | $6.56M derived: sum of 3 quarters · filed 2026-08-28 | $9.21M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2024-09-30 | $2.01M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | $4.50M derived: sum of 2 quarters · filed 2026-08-28 | $7.15M derived: sum of 3 quarters · filed 2026-08-28 | $9.44M 10-K/A · filed 2026-08-28 | ||||
| 2024-06-30 | $2.49M 10-Q · filed 2025-08-12 | $5.14M derived: sum of 2 quarters · filed 2025-08-12 | $7.42M 10-Q · filed 2025-08-12 | $10.61M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2024-03-31 | $2.65M 10-Q · filed 2025-05-13 | $4.94M 10-Q · filed 2025-05-13 | $8.13M derived: sum of 3 quarters · filed 2026-08-28 | $11.99M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2023-12-31 | $2.29M 10-Q · filed 2025-02-12 | $5.47M derived: sum of 2 quarters · filed 2026-08-28 | $9.34M derived: sum of 3 quarters · filed 2026-08-28 | $13.31M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2023-09-30 | $3.19M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | $7.05M derived: sum of 2 quarters · filed 2026-08-28 | $11.02M derived: sum of 3 quarters · filed 2026-08-28 | $16.37M 10-K/A · filed 2026-08-28 | ||||
| 2023-06-30 | $3.87M 10-Q · filed 2024-08-06 | $3.87M 10-Q · filed 2023-08-08 | $7.84M derived: sum of 2 quarters · filed 2024-08-06 | $13.18M 10-Q · filed 2024-08-06 | $13.18M 10-Q · filed 2023-08-08 | $19.23M derived: sum of 4 quarters · filed 2024-08-06 | ||
| 2023-03-31 | $3.97M 10-Q · filed 2024-05-09 | $3.97M 10-Q · filed 2023-05-09 | $9.32M 10-Q · filed 2024-05-09 | $9.32M 10-Q · filed 2023-05-09 | $15.36M derived: sum of 3 quarters · filed 2024-05-09 | $19.35M derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | $5.35M 10-Q · filed 2024-02-07 | $5.35M 10-Q · filed 2023-02-07 | $11.39M derived: sum of 2 quarters · filed 2024-02-07 | $15.38M derived: sum of 3 quarters · filed 2024-02-07 | $19.82M derived: sum of 4 quarters · filed 2024-02-07 | |||
| 2022-09-30 | $6.04M derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-27 | $10.03M derived: sum of 2 quarters · filed 2023-11-27 | $14.47M derived: sum of 3 quarters · filed 2023-11-27 | $18.38M 10-K · filed 2023-11-27 | $18.38M 10-K · filed 2022-11-28 | |||
| 2022-06-30 | $3.99M 10-Q · filed 2023-08-08 | $8.43M derived: sum of 2 quarters · filed 2023-08-08 | $12.34M 10-Q · filed 2023-08-08 | |||||
| 2022-03-31 | $4.44M 10-Q · filed 2023-05-09 | $8.35M 10-Q · filed 2023-05-09 | ||||||
| 2021-12-31 | $3.91M 10-Q · filed 2023-02-07 | |||||||
| 2021-09-30 | $8.23M 10-K · filed 2023-11-27 | $8.23M 10-K · filed 2021-11-24 | ||||||
| 2020-09-30 | $660.60K derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28 | $1.91M derived: sum of 2 quarters · filed 2022-11-28 | $3.61M derived: sum of 3 quarters · filed 2022-11-28 | $4.88M 10-K · filed 2022-11-28 | ||||
| 2020-06-30 | $1.25M 10-Q · filed 2020-08-06 | $2.95M derived: sum of 2 quarters · filed 2020-08-06 | $4.22M 10-Q · filed 2020-08-06 | $5.45M derived: sum of 4 quarters · filed 2020-12-28 | ||||
| 2020-03-31 | $1.70M 10-Q · filed 2020-05-07 | $2.97M 10-Q · filed 2020-05-07 | $4.20M derived: sum of 3 quarters · filed 2020-12-28 | $5.44M derived: sum of 4 quarters · filed 2020-12-28 | ||||
| 2019-12-31 | $1.26M 10-Q · filed 2020-02-06 | $2.50M derived: sum of 2 quarters · filed 2020-12-28 | $3.74M derived: sum of 3 quarters · filed 2020-12-28 | $5.63M derived: sum of 4 quarters · filed 2020-12-28 | ||||
| 2019-09-30 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-28 | $2.47M derived: sum of 2 quarters · filed 2020-12-28 | $4.36M derived: sum of 3 quarters · filed 2020-12-28 | $6.43M 10-K · filed 2020-12-28 | ||||
| 2019-06-30 | $1.23M 10-Q · filed 2020-08-06 | $3.13M derived: sum of 2 quarters · filed 2020-08-06 | $5.19M 10-Q · filed 2020-08-06 | $6.69M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | $1.89M 10-Q · filed 2020-05-07 | $3.96M 10-Q · filed 2020-05-07 | $5.45M derived: sum of 3 quarters · filed 2020-05-07 | $7.13M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $2.07M 10-Q · filed 2020-02-06 | $3.56M derived: sum of 2 quarters · filed 2020-02-06 | $5.24M derived: sum of 3 quarters · filed 2020-02-06 | $6.46M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-09-30 | $1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-16 | $3.17M derived: sum of 2 quarters · filed 2019-12-16 | $4.40M derived: sum of 3 quarters · filed 2019-12-16 | $5.52M 10-K · filed 2019-12-16 | ||||
| 2018-06-30 | $1.68M 10-Q · filed 2019-08-07 | $2.90M derived: sum of 2 quarters · filed 2019-08-07 | $4.03M 10-Q · filed 2019-08-07 | $5.14M derived: sum of 4 quarters · filed 2019-08-07 | ||||
| 2018-03-31 | $1.23M 10-Q · filed 2019-05-09 | $2.35M 10-Q · filed 2019-05-09 | $3.47M derived: sum of 3 quarters · filed 2019-05-09 | $4.63M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $1.12M 10-Q · filed 2018-02-07 | $2.24M derived: sum of 2 quarters · filed 2019-01-25 | $3.40M derived: sum of 3 quarters · filed 2019-01-25 | $4.37M derived: sum of 4 quarters · filed 2019-01-25 | ||||
| 2017-09-30 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-25 | $2.28M derived: sum of 2 quarters · filed 2019-01-25 | $3.25M derived: sum of 3 quarters · filed 2019-01-25 | $4.14M 10-K · filed 2019-01-25 | ||||
| 2017-06-30 | $1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-07 | $2.13M derived: sum of 2 quarters · filed 2017-08-07 | $3.02M 10-Q · filed 2017-08-07 | $6.80M derived: sum of 4 quarters · filed 2017-12-11 | ||||
| 2017-03-31 | $968.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-10 | $1.86M 10-Q · filed 2017-05-10 | $5.64M derived: sum of 3 quarters · filed 2017-12-11 | $5.87M derived: sum of 4 quarters · filed 2017-12-11 | ||||
| 2016-12-31 | $889.27K 10-Q · filed 2017-02-07 | $4.67M derived: sum of 2 quarters · filed 2017-12-11 | $4.90M derived: sum of 3 quarters · filed 2017-12-11 | $5.13M derived: sum of 4 quarters · filed 2017-12-11 | ||||
| 2016-09-30 | $3.79M derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-11 | $4.01M derived: sum of 2 quarters · filed 2017-12-11 | $4.24M derived: sum of 3 quarters · filed 2017-12-11 | $4.45M 10-K · filed 2017-12-11 | ||||
| 2016-06-30 | $228.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-11 | $450.95K derived: sum of 2 quarters · filed 2016-08-11 | $666.97K 10-Q · filed 2016-08-11 | |||||
| 2016-03-31 | $222.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-11 | $438.71K 10-Q · filed 2016-05-11 | ||||||
| 2015-12-31 | $216.02K 10-Q · filed 2016-02-08 | |||||||
| 2015-09-30 | $1.63M 10-K · filed 2017-12-11 | |||||||
| 2014-09-30 | $637.92K 10-K · filed 2016-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |